ArticleBMC gastroenterology2025

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma.

Guanzhi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.